Clinical Trials in Denver

Showing 2001-2020 of 15,604 trials

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

NCT03505099

To evaluate the safety and efficacy of intravenous onasemnogene abeparvovec-xioi in pre-symptomatic patients with SMA and 2 or 3 copies SMN2

Spinal Muscular Atrophy

Novartis Gene Therapies30 participantsStarted Apr 2018

Los Angeles, California, United States • Aurora, Colorado, United States • Orlando, Florida, United States +13 more locations

COMPLETEDPhase 38.4 miles

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

NCT03306277

Phase 3 pivotal US trial studying open-label intravenous administration of onasemnogene abeparvovec-xioi in spinal muscular atrophy (SMA) Type 1 participants.

SMA - Spinal Muscular AtrophyGene Therapy

Novartis Gene Therapies22 participantsStarted Oct 2017

Los Angeles, California, United States • Stanford, California, United States • Aurora, Colorado, United States +13 more locations

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Find Trials by Condition in Denver

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks

Replication and Evaluation of the RISE-APS Model In New Contexts

Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Social & Contextual Impact on Children Undergoing Liver Transplantation

A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Evaluating the Role of Inflammation in Neonatal Epileptogenesis

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery